These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 30706179)
1. Hereditary heart disease: pathophysiology, clinical presentation, and animal models of HCM, RCM, and DCM associated with mutations in cardiac myosin light chains. Yadav S; Sitbon YH; Kazmierczak K; Szczesna-Cordary D Pflugers Arch; 2019 May; 471(5):683-699. PubMed ID: 30706179 [TBL] [Abstract][Full Text] [Related]
2. Cardiomyopathic mutations in essential light chain reveal mechanisms regulating the super relaxed state of myosin. Sitbon YH; Diaz F; Kazmierczak K; Liang J; Wangpaichitr M; Szczesna-Cordary D J Gen Physiol; 2021 Jul; 153(7):. PubMed ID: 34014247 [TBL] [Abstract][Full Text] [Related]
3. Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function? Willott RH; Gomes AV; Chang AN; Parvatiyar MS; Pinto JR; Potter JD J Mol Cell Cardiol; 2010 May; 48(5):882-92. PubMed ID: 19914256 [TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of cardiomyopathy phenotypes associated with myosin light chain mutations. Huang W; Szczesna-Cordary D J Muscle Res Cell Motil; 2015 Dec; 36(6):433-45. PubMed ID: 26385864 [TBL] [Abstract][Full Text] [Related]
5. Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes. Xu Q; Dewey S; Nguyen S; Gomes AV J Mol Cell Cardiol; 2010 May; 48(5):899-909. PubMed ID: 20298698 [TBL] [Abstract][Full Text] [Related]
6. Hypercontractile mutant of ventricular myosin essential light chain leads to disruption of sarcomeric structure and function and results in restrictive cardiomyopathy in mice. Yuan CC; Kazmierczak K; Liang J; Kanashiro-Takeuchi R; Irving TC; Gomes AV; Wang Y; Burghardt TP; Szczesna-Cordary D Cardiovasc Res; 2017 Aug; 113(10):1124-1136. PubMed ID: 28371863 [TBL] [Abstract][Full Text] [Related]
7. Phosphomimetic-mediated in vitro rescue of hypertrophic cardiomyopathy linked to R58Q mutation in myosin regulatory light chain. Yadav S; Kazmierczak K; Liang J; Sitbon YH; Szczesna-Cordary D FEBS J; 2019 Jan; 286(1):151-168. PubMed ID: 30430732 [TBL] [Abstract][Full Text] [Related]
8. The molecular biology and pathophysiology of hypertrophic cardiomyopathy due to mutations in the beta myosin heavy chains and the essential and regulatory light chains. Epstein ND Adv Exp Med Biol; 1998; 453():105-14; discussion 114-5. PubMed ID: 9889820 [TBL] [Abstract][Full Text] [Related]
9. Molecular basis of force-pCa relation in Yuan CC; Kazmierczak K; Liang J; Ma W; Irving TC; Szczesna-Cordary D Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35177471 [TBL] [Abstract][Full Text] [Related]
10. Ablation of the N terminus of cardiac essential light chain promotes the super-relaxed state of myosin and counteracts hypercontractility in hypertrophic cardiomyopathy mutant mice. Sitbon YH; Kazmierczak K; Liang J; Yadav S; Veerasammy M; Kanashiro-Takeuchi RM; Szczesna-Cordary D FEBS J; 2020 Sep; 287(18):3989-4004. PubMed ID: 32034976 [TBL] [Abstract][Full Text] [Related]
12. Phosphorylation Mimetic of Myosin Regulatory Light Chain Mitigates Cardiomyopathy-Induced Myofilament Impairment in Mouse Models of RCM and DCM. Kazmierczak K; Liang J; Maura LG; Scott NK; Szczesna-Cordary D Life (Basel); 2023 Jun; 13(7):. PubMed ID: 37511838 [TBL] [Abstract][Full Text] [Related]
13. Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies. Hoedemaekers YM; Caliskan K; Majoor-Krakauer D; van de Laar I; Michels M; Witsenburg M; ten Cate FJ; Simoons ML; Dooijes D Eur Heart J; 2007 Nov; 28(22):2732-7. PubMed ID: 17947214 [TBL] [Abstract][Full Text] [Related]
14. Mavacamten decreases maximal force and Ca Awinda PO; Watanabe M; Bishaw Y; Huckabee AM; Agonias KB; Kazmierczak K; Szczesna-Cordary D; Tanner BCW Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H881-H890. PubMed ID: 33337957 [TBL] [Abstract][Full Text] [Related]
15. Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice. Yuan CC; Muthu P; Kazmierczak K; Liang J; Huang W; Irving TC; Kanashiro-Takeuchi RM; Hare JM; Szczesna-Cordary D Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4138-46. PubMed ID: 26124132 [TBL] [Abstract][Full Text] [Related]
16. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy. Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637 [TBL] [Abstract][Full Text] [Related]
17. Novel familial dilated cardiomyopathy mutation in MYL2 affects the structure and function of myosin regulatory light chain. Huang W; Liang J; Yuan CC; Kazmierczak K; Zhou Z; Morales A; McBride KL; Fitzgerald-Butt SM; Hershberger RE; Szczesna-Cordary D FEBS J; 2015 Jun; 282(12):2379-93. PubMed ID: 25825243 [TBL] [Abstract][Full Text] [Related]
18. Hypertrophic cardiomyopathy mutation R58Q in the myosin regulatory light chain perturbs thick filament-based regulation in cardiac muscle. Kampourakis T; Ponnam S; Irving M J Mol Cell Cardiol; 2018 Apr; 117():72-81. PubMed ID: 29452157 [TBL] [Abstract][Full Text] [Related]
19. Investigation of de novo variation in pediatric cardiomyopathy. Parrott A; Khoury PR; Shikany AR; Lorts A; Villa CR; Miller EM Am J Med Genet C Semin Med Genet; 2020 Mar; 184(1):116-123. PubMed ID: 31912959 [TBL] [Abstract][Full Text] [Related]
20. A Complete Absence of Missense Mutation in Myosin Regulatory and Essential Light Chain Genes of South Indian Hypertrophic and Dilated Cardiomyopathies. Rani DS; Nallari P; Rani J; Nizamuddin S; Seelamneni T; Narasimhan C; Thangaraj K Cardiology; 2018; 141(3):156-166. PubMed ID: 30605904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]